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1. Introduction 
Growth hormone secretion can be inhibited by a 
peptide, somatostatin, present in the hypothalamns 
and median eminence [ 1 ] . The mechanism of this 
inhibition is not known, but since somatostatin inhibits 
the secretion of several hormones in response to a wide 
range of in vitro stimuli [l-S] it probably affects a 
process common to the secretory pathways in all these 
cell types. This process may involve calcium ions since, 
for many cell types, a role for calcium in stimulus- 
secretion coupling has been suggested by several 
experimental techniques [6] . Some data show that the 
inhibition of hormone secretion by somatostatin can 
be reversed by increasing the concentration of calcium 
[3,7] or barium [8] ions, which suggest hat somato- 
statin could affect the provision of calcium to a secre- 
tory step. 
Recently, the antibiotic ionophore A23 187, which 
can complex with calcium and facilitate its movement 
through biological membranes [9] has been shown to 
stimulate secretion, increasing for example the release 
of histamine from mast cells [ 1 O] . If inhibition of 
growth hormone secretion by somatostatin does 
indeed involve a decrease in the permeability of the 
cell membrane to calcium, A23 187 would be expected 
to reverse the inhibition by overcoming the membrane 
permeability barrier. However, A23 187 did not increase 
growth hormone release from rat hemipituitaries, 
perhaps because of its poor penetration in the tissue 
[ 1 l] . We have therefore investigated the effect of 
A23 187 on growth hormone secretion from dispersed 
cells isolated from bovine anterior pituitaries by an 
North-Holland Publishing Company - Amsteraam 
enzymatic procedure, and the sensitivity of this secre- 
tion to somatostatin. 
2. Materials and methods 
2.1. Cell dispersion 
A pituitary gland removed from a heifer within 
5 min of slaughter was sliced [ 121 and incubated at 
37°C for 15 min in incubation medium A (composi- 
tion: NaCl, 118 mM; KCl, 5.9 mM; CaCl*, 0.25 mM; 
MgCl,, 0.3 mM; NaHCOsi 25 mM; and KHP04, 
1.2 mM; glucose, 2.8 mM; sodium 3-hydroxybktyrate, 
1.2 mM; penicillin (50 /,&ml); streptomycin, 40 pg/ml; 
bovine serum albumin (Sigma, fraction V) 2 mg/ml; 
containing the M.E.M. amino acid supplement and 
equilibrated with 02:C02 (95:5)). The slices were 
then cut into fragments 1 mm square and stirred for 
10 min in 10 ml medium A containing 10 mg Trypsin 
(Sigma Type Ill). The tissue fragments were then 
recovered by centrifugation, washed with 10 ml 
medium A containing 7.5 mg Soyabean Trypsin 
Inhibitor (Sigma Type I-S), and then incubated with 
stirring in 10 ml medium A containing Soyabean 
Trypsin Inhibitor and 960 units of collagenase 
(Sigma Type II). After 45 min the tissue fragments 
were recovered by centrifugation and partially dis- 
persed in 10 ml medium A by drawing them up about 
40 times into a 5 ml plastic syringe through a plastic 
tube (5 X 0.25 cm). Undigested tissue fragments were 
allowed to settle for 2 min, the supernatant con- 
taining dispersed cells was removed and the tissue 
fragments stirred for 15 min in the original collagenase 
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containing medium. At the end of this incubation the 
dispersion procedure was repeated and the two cell 
suspensions pooled. The suspension was then filtered 
through a nylon gauze (68 GGN: Henry Simon Ltd, 
Stockport, Cheshire, SK3 ORT). A yield of approxi- 
mately 2.5 X lo6 cells was obtained, and the cells 
were SS-90% viable by Trypan Blue exclusion. 
2.2. Cell perifusi& 
The cells were removed by centrifugation (Position 1 
on MSE bench centrifuge) and approximately 
12 X 1 O6 cells incubated for 120 min in 1 ml medium B 
(Composition:NaCl, 118 mM; KCl, 5.9 mM; NaHCOa, 
25 mM; KH2P04 1.2 mM; glucose, 2.8 mM; sodium 
3-hydroxybutyrate 1.2 mM; albumin 0.5 mg/ml) 
containing 45Ca2+ (20 &r; 23 PM). The cells were 
then recovered by centrifugation, resuspended in 
1 ml fresh medium B and 300 4 aliquots added to 
three PVC columns (0.4 X 0.75 cm) containing 
Sephadex G-10 acetylated to decrease 45Ca2+ adhesion 
[13]. The columns were then placed in a 37°C cabinet 
and eluted with medium B containing 2.5 mM CaC12, 
at a flow rate of 0.2 ml/min: collecting 2 min frac- 
tions. At the end of this perifusion, media were stored 
at -20% before radioimmunoassay of growth hormone 
[ 121 and measurement of 45Ca2’ by liquid scintillation. 
Linear somatostatin was given by Dr R. Guillemin 
of the Salk Institute, and was stored at -20°C as a 
1 mg/ml solution in 0.9% NaCl. A23 187 was obtained 
from Dr Otto Behrens of Eli Lilly, and was stored at 
-20°C as a 10 mg/ml solution in dimethylsulphoxide 
(DMSO). 
3. Results 
Release of growth hormone from bovine pituitary 
slices [14] and from rat hemipituitaries [8] is 
stimulated by BaC12, and this stimulation is sensitive 
to somatostatin inhibition [8]. Release of growth 
hormone from the dispersed bovine pituitary cell 
preparation was also stimulated by BaC12, and 
inhibited by somatostatin. The data in fig. 1 represent 
the average for three experiments on three cell prepara- 
tions and show that during perifusion with BaC12 
(2 mM) in the presence of somatostatin (1 pg/ml) 
considerably less growth hormone was released than 
during a subsequent perifusion with BaC12 alone. After 
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Fig.1. Effect of BaCl, and somatostatin on bovine GH 
release from perifused pituitary cell preparations. Data show 
mean bovine GH release obtained from perifusion of three 
pituitary cell preparations with medium in which BaCl, 
(2 mM) was present during the period shown by the 
open bar and in which BaCl, (2 mM) and somatostatin 
(1 pg/ml) were present during the period shown by the 
solid bar. 
removal of BaC12 and somatostatin, the rate of growth 
hormone release returned rapidly to basal values. 
A23 187 (10 pg/ml) also increased growth hormone 
release from the dispersed cells; in four experiments, 
the mean rate of release during 20 min in the presence 
of A23 187 was 0.866 + 0.013 pg/min compared to 
0.216 f 0.013 pg/min in control medium during the 
previous 20 min. Addition of DMSO alone did not alter 
growth hormone release (data not shown). The 
increase in growth hormone release caused by A23 187 
was inhibited by somatostatin (1 pg/ml); with the same 
four preparations the mean rate of release during 
20 min perifusion in the presence of A23 187 and 
somatostatin was 0.386 + 0.028 pg/min compared to 
0.220 + 0.009 pg/min in the previous 20 min. Neither 
A23 187 nor somatostatin affected the growth hormone 
assay (data not shown). Following removal of A23 187 
from the medium, the rate of growth hormone release 
slowly decreased towards basal values (fig.2a); it is 
not clear whether this slow reversal represents low 
removal of A23 187 from ceil membranes or a slow 
restoration of the normal internal ion concentrations. 
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Fig.2. Effect of A23187 and somatostatin on bovine GH release and *‘Ca’* efflux from perifused pituitary cell preparations. 
Figs. 2a and 2c show the mean bovine GH release and ‘5Ca’+ efflux from two pituitary cell preparations perifused with medium 
in which A23187 (10 &ml) was present during the period shown by the open bar. Figs.2b and 2d show the corresponding data 
obtained from identical aliquots of the same two pituitary cell preparations perifused in parallel with medium in which A23187 
(10 rg/ml) and somatostatin (1 pg/ml) were present during the period shown by the solid bar. 
However, following removal of A23 187 and somato- 
statin there was a transient increase in growth hormone 
release as would be expected if the effect of somato- 
statin was more rapidly reveratsed than that of 
A231 87 (IIg.2b). 
As would be expected if membrane calcium 
permeability were altered, A23 187 increased the rate 
of 45Ca2+ efflux from the cells (fig.2c); since the 
external calcium concentration was 2.5 mM, this 
efflux of radioactivity presumably represents exchange 
rather than net calcium movement. Somatostatin did 
not prevent the increase in 45CaF efflux (fig.2d). 
4. Discussion 
The experiments reported here show that A23 187 
can increase growth hormone release from dispersed 
bovine pituitary cells. The lack of effect of the iono- 
phore on growth hormone release from intact tissue 
previously reported [ 111 was therefore presumably 
due to poor penetration of the tissue by the iono- 
phore. The ability of somatostatin to inhibit the 
growth hormone release induced by A23 187 
strongly suggests that the release did not result from 
cell damage, and is of some interest to understanding 
the mechanism of somatostatin action. It has been 
suggested that somatostatin acts by decreasing tissue 
cyclic AMP [ 15 ] or increasing cyclic GMP [ 161 con- 
centrations, by inhibiting calcium entry into cells 
[5] or inhibiting a calcium-dependent process in 
secretion [7]. The data presented here show that 
although somatostatin inhibits the growth hormone 
release from pituitary cells induced by A23 187, it does 
not prevent the 4sCa2+ efflux caused by the ionophore. 
The detailed explanation of this 45Ca2+ efflux is 
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complex, but since the external Ca*+ concentration 
was 2.5 mM, it presumably represents an increase in 
isotope exchange from tissue stores following an 
increase in cytoplasmic calcium concentration caused 
by the ionophore. Since somatostatin did not affect 
this efflux, it does not apparently modify the action 
of A23 187 on membrane calcium permeability or 
the redistribution> of calcium. Thus it would appear 
that somatostatin can inhibit the secretory process 
in the presence of calcium at stimulatory concentra- 
tions in the anterior pituitary. It is interesting to 
contrast these results with those obtained in isolated 
pancreatic islets where somatostatin (1 pg/ml) poten- 
tiated insulin and glucagon release in the presence of 
A23 187, which was explained as being dLe to 
decreased calcium efflux [ 51. 
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